Moreover, our in silico gene expression analysis indicated an association with high MTHFD2 mRNA expression and characteristics of poor outcome in clinical breast cancer samples, indicating that MTHFD2 may promote disease progression. This evidence concerns the gene MTHFD2 and breast carcinoma.